arrow
D

Daniela Silvestri

tettamanti center
H指数:36
被引数:4,675

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy

AIEOP-BFM ALL 2009试验中接受治疗的儿童T-ALL患者的结果:现代风险适应疗法背景下的预后因素

2025-09-020
OAAI
Results in Pediatric T-ALL Patients Treated in Trial AIEOP-BFM ALL 2009: Exploring Prognostic Factors in the Context of Modern Risk Adapted Therapy

儿童T-ALL患者在接受AIEOP-BFM ALL 2009试验治疗后的结果:在现代化风险适应治疗背景下探索预后因素

BLOOD
IF23.1
2024-11-050
PRE
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

高通量筛选作为小儿B细胞前体急性淋巴细胞白血病不良结局亚组的药物再利用策略

2023-11-018
OAAI
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease

miR-126确定了与最小残留疾病相关的静止和化疗耐药的人类b-all细胞亚群

LEUKEMIA
IF13.4
2023-08-282
PRE
Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP-BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia
2023-08-241
PRE
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
2023-06-013
OAAI
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia

Ph样和IKZF1plus状态在儿童唐氏综合征和b细胞前体急性淋巴细胞白血病中的定义和预后价值

2023-06-019
OAAI
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
2023-06-017
OAAI
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
2023-04-061
OAAI
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

PAX5融合基因在低风险儿童急性淋巴细胞白血病中很常见,可以用BIBF1120靶向

2022-09-0115
OAAI
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia
2021-03-0123
OAAI
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study
2019-11-0115
PREAI
A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B-cell Acute Lymphoblastic Leukemia

一种简单的RNA靶标捕获NGS策略,用于儿童b细胞急性淋巴细胞白血病的诊断中融合基因评估

2019-05-2214
OAAI
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
2019-01-3136
OAAI
Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
2018-11-156
OAAI
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis
2016-02-0197
PREAI